Methods of predicting therapeutic response in atopic dermatitis to IL-31 antagonists

Details for Australian Patent Application No. 2006214326 (hide)

Owner ZymoGenetics, Inc. National Jewish Medical and Research Center

Inventors Bilsborough, Janine; Gross, Jane A.; Leung, Donald Y.M.

Agent Griffith Hack

Pub. Number AU-B-2006214326

PCT Pub. Number WO2006/088956

Priority 60/749,952 13.12.05 US; 60/653,114 14.02.05 US; 60/716,762 13.09.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 29 September 2011

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088956 Priority application(s): WO2006/088956

13 September 2007 Amendment Made

  The nature of the amendment is: Amend the coinventor name from Billsborough, Janine to Bilsborough, Janine

29 September 2011 Application Accepted

  Published as AU-B-2006214326

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214332-Replikin peptides and uses thereof

2006214325-Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells